Compagnie Lombard Odier S Cm A Amgen Inc Transaction History

Compagnie Lombard Odier S Cm A

$6.12 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 16, 2024	SELL	$255.7 - $288.46 $1.43 Million - $1.62 Million	-5,609 Reduced 4.0%	134,692 $38.8 Million
Q3 2023 Oct 23, 2023	BUY	$218.65 - $271.46 $30.7 Million - $38.1 Million	140,301 New	140,301 $37.7 Million
Q1 2023 May 01, 2023	BUY	$225.79 - $275.2 $2.9 Million - $3.53 Million	12,828 Added 10.89%	130,665 $31.6 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $22.1 Million - $28.1 Million	-96,598 Reduced 45.05%	117,837 $31 Million
Q3 2022 Nov 09, 2022	BUY	$224.46 - $253.15 $9.24 Million - $10.4 Million	41,174 Added 23.76%	214,435 $48.3 Million
Q2 2022 Aug 11, 2022	BUY	$230.71 - $256.74 $2.63 Million - $2.92 Million	11,384 Added 7.03%	173,261 $42.1 Million
Q1 2022 Apr 27, 2022	BUY	$219.27 - $242.57 $13.7 Million - $15.1 Million	62,444 Added 62.8%	161,877 $39.1 Million
Q4 2021 Feb 09, 2022	BUY	$198.88 - $227.6 $4.65 Million - $5.32 Million	23,375 Added 30.73%	99,433 $22.4 Million
Q3 2021 Oct 28, 2021	BUY	$212.27 - $248.7 $94,672 - $110,920	446 Added 0.59%	76,058 $16.2 Million
Q2 2021 Jul 15, 2021	SELL	$233.58 - $259.14 $1.32 Million - $1.46 Million	-5,641 Reduced 6.94%	75,612 $18.4 Million
Q1 2021 Apr 23, 2021	SELL	$221.91 - $258.6 $1.18 Million - $1.37 Million	-5,313 Reduced 6.14%	81,253 $20.2 Million
Q4 2020 Feb 09, 2021	BUY	$216.38 - $257.67 $922,860 - $1.1 Million	4,265 Added 5.18%	86,566 $19.9 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $27,454 - $30,531	-117 Reduced 0.14%	82,301 $20.9 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $29,869 - $36,653	151 Added 0.18%	82,418 $19.4 Million
Q1 2020 May 13, 2020	BUY	$182.24 - $241.7 $156,544 - $207,620	859 Added 1.06%	82,267 $16.7 Million
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $222,510 - $286,003	1,176 Added 1.47%	81,408 $19.6 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $918,778 - $1.1 Million	-5,277 Reduced 6.17%	80,232 $15.5 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $819,330 - $960,440	4,915 Added 6.1%	85,509 $15.8 Million
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $22.2 Million - $25 Million	-122,820 Reduced 60.38%	80,594 $15.3 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $149,856 - $174,930	840 Added 0.41%	203,414 $39.6 Million
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $920,891 - $1.04 Million	4,970 Added 2.52%	202,574 $42 Million
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $1.13 Million - $1.27 Million	-6,805 Reduced 3.33%	197,604 $36.5 Million
Q1 2018 May 11, 2018	SELL	$169.43 - $198.0 $186,203 - $217,602	-1,099 Reduced 0.53%	204,409 $34.8 Million
Q4 2017 Feb 13, 2018	SELL	$168.79 - $188.59 $1.19 Million - $1.33 Million	-7,044 Reduced 3.31%	205,508 $35.7 Million
Q3 2017 Nov 14, 2017	SELL	$167.29 - $191.0 $3.35 Million - $3.82 Million	-20,013 Reduced 8.61%	212,552 $39.6 Million
Q2 2017 Aug 14, 2017	BUY	N/A	232,565	232,565 $40.1 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

News

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.

Account